Chronic Kidney Diseases, Covid19, Proteinuria
Conditions
Brief summary
COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (\> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.
Detailed description
The chronis kidney disease patients followed in Nephrology outpatient unit are going to be enrolled in the study and their kidney functions (calculated with the mdrd formula to asses the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.
Interventions
OTHERchange in kidney function and proteinuria
change in eGFR nad proteinuria in patients with chronic kidney disease
Sponsors
Uşak University
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* patients with chronic kidney disease on regular follow-up for 6 months before the COVID19 pandemic.
Exclusion criteria
* patients without chronic kidney disease * patients not on routine follow-up for 6 months before the COVID19 pandemic
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| eGFR change | 6 months | a rise or decrease in eGFR |
| change in proteinuria | 6 months | increase or decrease in ptoteinuria levels |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| initiation of renal replacement therapies | 6 months | need for hemodialysis or peritoneal dialysis |
Countries
Turkey (Türkiye)
Outcome results
None listed